{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:17:35Z","timestamp":1698668255860},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T00:00:00Z","timestamp":1357084800000},"content-version":"vor","delay-in-days":178,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Andrology"],"published-print":{"date-parts":[[2012,7,8]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> High\u2010flow priapism most often occurs following perineal and penile trauma. We report the case of a 29\u2010year\u2010old man who presented with recurrent priapism and was initially treated with corporal aspiration and intracavernosal injections on multiple emergency department visits and then condition\u2010controlled with sibutramine while on treatment for weight loss. His condition relapsed after the medication was withdrawn from the market, necessitating medical intervention.<\/jats:p>","DOI":"10.2164\/jandrol.111.013177","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T09:40:55Z","timestamp":1342172455000},"page":"566-569","source":"Crossref","is-referenced-by-count":2,"title":["Sibutramine for the Treatment of Recurrent High\u2010Flow Priapism"],"prefix":"10.1002","volume":"33","author":[{"given":"Saleh","family":"Binsaleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,1,2]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35219-9"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.150.1.47"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01464-9"},{"key":"e_1_2_4_5_1","first-page":"82","article-title":"Metachronous recurrence of idiopathic high flow priapism","volume":"57","author":"Guerra Cruz NA","year":"2004","journal-title":"Arch Esp Urol"},{"key":"e_1_2_4_6_1","volume-title":"European Medicines Agency recommends suspension of marketing authorisation for sibutramin","author":"European Medicines Agency","year":"2010"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X38132"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66444-9"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64299-1"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000280878"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2007.06.030"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000281226"},{"key":"e_1_2_4_13_1","first-page":"1318","article-title":"Members of the Erectile Dysfunction Guideline Update Panel; American Urological Association. American Urological Association guideline on the management of priapism","volume":"170","author":"Montague DK","year":"2003","journal-title":"JUrol"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)67730-9"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01838.x"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2004.10117.x"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)02162-9"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00045-9"},{"key":"e_1_2_4_19_1","first-page":"1361","article-title":"Use of methylene blue and selective embolization of the pudendal artery for high\u2010flow priapism refractory to medical and surgical treatments","volume":"146","author":"Steers WD","year":"1991","journal-title":"JUrol"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm217"},{"key":"e_1_2_4_21_1","volume-title":"Meridia (sibutramine hydrochloride): follow\u2010up to an early communication about an ongoing safety revie","author":"US Food and Drug Administration"},{"key":"e_1_2_4_22_1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/S1677-55382003000500002","article-title":"Priapism: etiology, pathophysiology and management","volume":"29","author":"Horst C","year":"2003","journal-title":"Int Braz J Urol"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.061259"}],"container-title":["Journal of Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.2164%2Fjandrol.111.013177","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.2164\/jandrol.111.013177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T02:07:14Z","timestamp":1698631634000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.2164\/jandrol.111.013177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7,8]]}},"alternative-id":["10.2164\/jandrol.111.013177"],"URL":"https:\/\/doi.org\/10.2164\/jandrol.111.013177","archive":["Portico"],"relation":{},"ISSN":["0196-3635","1939-4640"],"issn-type":[{"value":"0196-3635","type":"print"},{"value":"1939-4640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,8]]}}}